| Absorption | 
      | Blood-Brain Barrier | BBB- | 0.9818 | 
      | Human Intestinal Absorption | HIA+ | 0.8932 | 
      | Caco-2 Permeability | Caco2- | 0.7657 | 
      | P-glycoprotein Substrate | Substrate | 0.7254 | 
      | P-glycoprotein Inhibitor | Non-inhibitor | 0.7046 | 
                                                     | Non-inhibitor | 0.8382 | 
      | Renal Organic Cation Transporter | Non-inhibitor | 0.9445 | 
        
            | Distribution | 
        
      | Subcellular localization | Mitochondria | 0.8326 | 
        
          | Metabolism | 
        
      | CYP450 2C9 Substrate | Non-substrate | 0.7049 | 
      | CYP450 2D6 Substrate | Non-substrate | 0.8777 | 
      | CYP450 3A4 Substrate | Substrate | 0.6511 | 
      | CYP450 1A2 Inhibitor | Non-inhibitor | 0.9046 | 
      | CYP450 2C9 Inhibitor | Non-inhibitor | 0.9070 | 
        | CYP450 2D6 Inhibitor | Non-inhibitor | 0.9294 | 
      | CYP450 2C19 Inhibitor | Non-inhibitor | 0.9026 | 
      | CYP450 3A4 Inhibitor | Non-inhibitor | 0.8308 | 
      | CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.7061 | 
        
          | Excretion | 
        
        
          | Toxicity | 
        
      | Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9958 | 
                                                                    | Non-inhibitor | 0.8052 | 
      | AMES Toxicity | Non AMES toxic | 0.8227 | 
      | Carcinogens | Non-carcinogens | 0.8554 | 
      | Fish Toxicity | High FHMT | 0.9547 | 
      | Tetrahymena Pyriformis Toxicity | High TPT | 0.8986 | 
      | Honey Bee Toxicity | Low HBT | 0.6051 | 
      | Biodegradation | Not ready biodegradable | 0.9943 | 
      | Acute Oral Toxicity | III | 0.7116 | 
      | Carcinogenicity (Three-class) | Non-required | 0.6683 |